DiaMedica Therapeutics Statistics
NASDAQ: DMACHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.99-0.14 (-1.72%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
DiaMedica Therapeutics by the numbers
DiaMedica Therapeutics has a market capitalization of $430.9 million based on 53.93M shares outstanding. With trailing EPS of $-0.72, DiaMedica Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.9% above its 50-day average and 12.6% above its 200-day average.
Average daily trading volume is 177.47K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
DMAC valuation vs. peer median
| Metric | DMAC | Peer median | Difference |
|---|---|---|---|
| Market cap | $430.87M | $445.34M | -3% |
| Avg. volume | 177.47K | 981.92K | -82% |
Peer median across 8 companies: PRTA, SPRY, RZLT, KMDA, OVID, ASMB, CAPR, AVIR.
Valuation
- Market cap
- $430.87M
- EPS (TTM)
- $-0.72
- Shares outstanding
- 53.93M
Price and trading
- Previous close
- 8.13
- Open
- 8.01
- Day range
- 7.95 – 8.42
- 52-week range
- 5.25 – 10.42
- 52-week change
- +16.47%
- Beta
- —
- Volume
- 220.73K
- Average volume
- 177.47K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 10, 2026
Additional statistics
- Market Cap
- 430.87M
- Forward Pe
- -9.89
- Eps
- -0.72
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.42
- Week52 Low
- 5.25
- Avg Volume
- 177.47K
- Shares Outstanding
- 53.93M
- Ma50
- 6.95
- Ma200
- 7.10
- Earnings Date
- Aug 10, 2026
- Pct From52w High
- -23.32%
- Pct From52w Low
- 52.34%